SMARCB1 and rhabdoid tumor: In addition, ~90% of malignant rhabdoid tumors (MRT) harbor SNF5/SMARCB1 (integrase interactor 1/SWI/SNF‐related matrix‐associated actin‐dependent regulator of chromatin subfamily B member 1) mutations54.